A Comparison of Transradial and Transfemoral Percutaneous Coronary Intervention in Chinese Women Based on a Propensity Score Analysis
- Author:
Yi XU
1
;
Chen JIN
;
Shubin QIAO
;
Yongjian WU
;
Hongbing YAN
;
Kefei DOU
;
Bo XU
;
Jingang YANG
;
Yuejin YANG
Author Information
- Publication Type:Original Article
- Keywords: Coronary artery disease; Percutaneous coronary intervention; Women; Radial artery; Femoral artery
- MeSH: Asian Continental Ancestry Group; Beijing; Bias (Epidemiology); China; Coronary Artery Disease; Death; Female; Femoral Artery; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Incidence; Myocardial Infarction; Percutaneous Coronary Intervention; Propensity Score; Radial Artery
- From:Korean Circulation Journal 2018;48(8):719-727
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND AND OBJECTIVES: Over the past decades, transradial approach for percutaneous coronary intervention (PCI) has been increasingly adopted in clinical practice. Women represent a large population who will possibly benefit from PCI, but they are often under-represented in clinical studies. Therefore, the role of TRI in women remains to be further defined. This study sought to compare safety and efficacy for transradial intervention (TRI) and transfemoral intervention (TFI) in women undergoing PCI in China. METHODS: The study population consisted of 5,067 women undergoing PCI at Fuwai Hospital, Beijing, China between 2006 and 2011 (TRI: n=4,105, TFI: n=962). Incidence rates of clinical outcomes during hospitalization and at 1-year follow-up were compared between TRI and TFI. In order to minimize potential biases, a 1:1 propensity score matching (PSM) was performed. A total of 899 pairs were matched. RESULTS: Baseline and procedural characteristics were well-balanced between TRI and TFI groups after controlling for confounders using PSM. TRI was associated with reduced major post-PCI bleeding (odds ratio [OR], 0.64; 95% confidence interval [CI], 0.54–0.76; p < 0.001) and access site complications (OR, 0.67; 95% CI, 0.61–0.74; p < 0.001) after PSM. There was no statistical differences in the incidence rates of major adverse cardiac events (a composite of cardiac death, myocardial infarction, and target vessel revascularization) both during hospitalization and at 1-year follow-up (p > 0.05). CONCLUSIONS: In this propensity score-based analysis of TRI versus TFI in Chinese women, TRI showed advantages of safety and feasibility over TFI. A wider adoption of TRI in women has the potential to improve outcomes in treatment of coronary artery diseases.
